Biomarker-based Companion Diagnostics Are Enabling Precision Oncology

Clinical trials are underway to examine the efficacy of various immune checkpoint inhibitor molecules, for the treatment of cancer.

Watch this video to learn about the companion diagnostics that are enabling the identification of patients who could benefit from these treatments.